NIVF Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for NewGenIvf Group Ltd (NIVF.O) is 0.25, compared to its 5-year average forward P/E of 0.06. For a more detailed relative valuation and DCF analysis to assess NewGenIvf Group Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.06

Current PE

0.25

Overvalued PE

0.31

Undervalued PE

-0.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.02

Overvalued PS

0.02

Undervalued PS

-0.01

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

NIVF News & Events

Events Timeline

No data

News

4.5

2025-12-12Newsfilter

NewGenIVF Converts Project to Joint Development, Expected Profit Increases to $123 Million

9.5

2025-12-02SeekingAlpha

NewGenIvf Reports GAAP EPS of $96.76 and Revenue of $3.30 Million

7.5

2025-10-31Newsfilter

NewGen Signs Groundbreaking Digital Assets Purchase Agreement with White Lion to Acquire Up to 600,000 Solana Tokens Worth Over $110 Million

People Also Watch

Frequently Asked Questions

What is NewGenIvf Group Ltd (NIVF) stock price today?

The current price of NIVF is 0.61 USD — it has decreased -1.61 % in the last trading day.

What is NewGenIvf Group Ltd (NIVF)'s business?

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.

What is the price predicton of NIVF Stock?

Wall Street analysts forecast NIVF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NIVF is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NewGenIvf Group Ltd (NIVF)'s revenue for the last quarter?

NewGenIvf Group Ltd revenue for the last quarter amounts to 1.28M USD, decreased -12.94 % YoY.

What is NewGenIvf Group Ltd (NIVF)'s earnings per share (EPS) for the last quarter?

NewGenIvf Group Ltd. EPS for the last quarter amounts to 195.38 USD, decreased -2093.67 % YoY.

What changes have occurred in the market's expectations for NewGenIvf Group Ltd (NIVF)'s fundamentals?

The market is revising No Change the revenue expectations for NIVF for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -93.58%.

How many employees does NewGenIvf Group Ltd (NIVF). have?

NewGenIvf Group Ltd (NIVF) has 76 emplpoyees as of January 08 2026.

What is NewGenIvf Group Ltd (NIVF) market cap?

Today NIVF has the market capitalization of 816.62K USD.